Hepatitis C Screening Alerts

Completed

Conditions studied: Hepatitis C

In brief

The objective of this study is to evaluate whether alerts that identify patients without hepatitis C infection to healthcare providers and clinic staff can increase the uptake of screening for hepatitis C. A period of time without alerts will be compared to a period of time with alerts.

Key facts

Study ID

NCT05710120

Run by

Epividian

People needed

125706

Starts

2023-01-16

Expected to finish

2023-10-17

Last updated by the study team

2024-02-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18+ years of age
• In care at an AIDS Healthcare Foundation Healthcare Center
• HCV screening eligible
• Individuals who are HCV screening eligible include:
• HCV unknown: Never received an HCV antibody, RNA, or genotype test
• Previously HCV negative, high-risk for HCV infection: HIV-infected men who have sex with men or people who inject drugs with ≥ 1 prior negative HCV antibody or RNA test(s) who have not been screened in the prior 12 months

You may not qualify if…

• <18 years of age
• Diagnosed HCV infection (i.e., reactive HCV antibody, detectable HCV RNA test, or HCV genotype test)
• Individuals with diagnosed HCV infection include:
• Acute HCV infection, untreated or in treatment
• Chronic HCV infection, untreated or in treatment
• Spontaneous clearance of prior HCV infection
• Sustained virologic response after direct acting antiviral therapy for prior HCV infection
• Treatment failure after direct acting antiviral therapy for prior HCV infection

Where it is running

• AIDS Healthcare Foundation — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.